AAP: Nirsevimab Benefits Beyond the First Year After Birth
Article Link INTRODUCTION Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract (LRTI) globally and the second leading pathogen to cause infant mortality.1,2 Most deaths occur in low-…
Read More from AAP: Nirsevimab Benefits Beyond the First Year After Birth